Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer

다국어 초록 (Multilingual Abstract)

Objective: Evaluation of the impact of sequential chemoradiotherapy in high risk endometrial cancer (EC).
Methods: Two hundred fifty-four women with stage IB grade 3, II and III EC (2009 FIGO staging), were included in this retrospective study.
Results: Stage I, II, and III was 24%, 28.7%, and 47.3%, respectively. Grade 3 tumor was 53.2% and 71.3% had deep myometrial invasion. One hundred sixty-five women (65%) underwent pelvic (+/– aortic) lymphadenectomy and 58 (22.8%) had nodal metastases. Ninety-eight women (38.6%) underwent radiotherapy, 59 (23.2%) chemotherapy, 42 (16.5%) sequential chemoradiotherapy, and 55 (21.7%) were only observed. After a median follow-up of 101 months, 78 women (30.7%) relapsed and 91 women (35.8%) died. Sequential chemoradiotherapy improved survival rates in women who did not undergo nodal evaluation (disease-free survival [DFS], p=0.040; overall survival [OS], p=0.024) or pelvic (+/– aortic) lymphadenectomy (DFS, p=0.008; OS, p=0.021). Sequential chemoradiotherapy improved both DFS (p=0.015) and OS (p=0.014) in stage III, while only a trend was found for DFS (p=0.210) and OS (p=0.102) in stage I–II EC. In the multivariate analysis, only age (≤65 years) and sequential chemoradiotherapy were statistically related to the prognosis.
Conclusion: Sequential chemoradiotherapy improves survival rates in high risk EC compared with chemotherapy or radiotherapy alone, in particular in stage III.

참고문헌 (Reference)

• 1 Nout RA, "Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of highintermediate risk (PORTEC-2): an open-label, non-inferiority, randomized trial" 375 : 816-823, 2010
• 2 Crivellaro C, "Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT" 130 : 306-311, 2013
• 3 Benedetti Panici P, "Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma:randomized clinical trial" 100 : 1707-1716, 2008
• 4 Signorelli M, "Synchronous early-stage endometrial and ovarian cancer" 102 : 34-38, 2008
• 5 Creasman WT, "Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study" 60 (60): 2035-2041, 1987
• 6 Hogberg T, "Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer: results from two randomised studies" 46 : 2422-2431, 2010
• 7 Randall ME, "Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study" 24 : 36-44, 2006
• 8 Susumu N, "Randomized phase III trial of pelvic radiotherapy versus cisplatinbased combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study" 108 : 226-233, 2008
• 9 Creasman WT, "Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium" 95 : 593-596, 2004
• 10 Aalders J, "Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients" 56 : 419-427, 1980
• 11 Milgrom SA, "Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer" 130 : 436-440, 2013
• 12 Long KC, "Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer" 125 : 99-102, 2012
• 13 Creutzberg CL, "Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients:the Postoperative Radiation Therapy in Endometrial Carcinoma Trial" 22 : 1234-1241, 2004
• 14 Klopp AH, "Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation" 115 : 6-11, 2009
• 15 Guntupalli SR, "Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer" 124 : 31-35, 2012
• 16 Greven K, "Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer" 103 : 155-159, 2006
• 17 Hoekstra AV, "FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes" 114 : 273-278, 2009
• 18 Bakkum-Gamez JN, "Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy" 132 : 578-584, 2014
• 19 Creasman WT, "Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer" 95 (95): S105-S143, 2006
• 20 Siegel R, "Cancer statistics" 63 : 11-30, 2013
• 21 Tewari KS, "Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study" 125 : 87-93, 2012
• 22 Kong A, "Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis" 104 : 1625-1634, 2012
• 23 Maggi R, "Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial" 95 : 266-271, 2006